Hem › Icke-småcellig lungcancer › Ohio › Akron
Kliniska studier för Icke-småcellig lungcancer i Akron, OH
22 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Akron (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekryterarFas 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · 21 mi bort
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekryterarFas 3
- Aultman Health Foundation, Canton · 21 mi bort
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RekryterarFas 3
- Akron General Medical Center, Akron
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekryterarFas 3
- Aultman North, North Canton · 15 mi bort
- Aultman Massillon, Massillon · 20 mi bort
- Aultman Orrville Hospital, Orrville · 21 mi bort
- och 2 fler
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
RekryterarFas 3
- Research Site, Canton · 21 mi bort
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekryterarFas 3
- Aultman Hospital, Canton · 21 mi bort
Pan-tumor MRD Study
RekryterarObservationsstudie
- Gabrail Cancer Center, Canton · 21 mi bort
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekryterarFas 2/3
- Gabrail Cancer Center Research, Canton · 21 mi bort
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
RekryterarFas 2
- Gabrail Cancer Center, Canton · 21 mi bort
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekryterarFas 2/3
- Tricounty Hematology and Oncology - Massillon, Massillon · 20 mi bort
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
RekryterarFas 1/2
- Gabrail Cancer Center Research, Canton · 21 mi bort
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RekryterarFas 3
- Gabrail Cancer Center, Canton · 21 mi bort
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RekryterarFas 2
- Gabrail Cancer and Research Center, Canton · 21 mi bort
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekryterarFas 2
- Cleveland Clinic Mercy Hospital, Canton · 21 mi bort
- Aultman Health Foundation, Canton · 21 mi bort
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- Aultman Health Foundation, Canton · 21 mi bort
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- Aultman Health Foundation, Canton · 21 mi bort
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2/3
- Aultman Health Foundation, Canton · 21 mi bort
GEMINI-NSCLC: NSCLC Biomarker Study
RekryterarObservationsstudie
- Aultman Hospital, Canton · 21 mi bort
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RekryterarFas 1
- Gabrail Cancer & Research Center, Canton · 21 mi bort
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekryterarFas 1/2
- Research Site 138, Canton · 21 mi bort
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
RekryterarFas 1/2
- Gabrail Cancer Center Research, Canton · 21 mi bort
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
RekryterarFas 1/2
- Gabrail Cancer Research Center, Canton · 21 mi bort
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY120 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH56 studier
- Washington, DC55 studier
Andra studier i Akron
- Lungcancer16 studier
- Cancer (alla typer)13 studier
- Bröstcancer13 studier
- Prostatacancer9 studier
- Akut myeloid leukemi8 studier
- Melanom8 studier
- Småcellig lungcancer8 studier
- Metastaserande cancer8 studier
- Kolorektal cancer8 studier
- Steatotisk leversjukdom7 studier
- Endometriecancer6 studier
- Äggstockscancer6 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.